Alyeska Investment Group
CLSD

Alyeska Investment Group’s Clearside Biomedical CLSD Stock Holding History

Alyeska Investment Group’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,000
Closed -$1.05M – 466
2016
Q2 		$1.05M Buy
+10,000
New +$1.05M 0.01% 386

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Alyeska Investment Group's CLSD Position: Q3 2016 in Review

Alyeska Investment Group sold out of Clearside Biomedical (CLSD) in Q3 2016, closing a stake of 10,000 shares — an estimated $1.05M sold.

Alyeska Investment Group first reported a position in CLSD in Q2 2016 and held it in 1 quarter. The position peaked at $1.05M in Q2 2016. 30 funds tracked by Wall St. Rank hold CLSD as of Q3 2016.

  • Alyeska Investment Group reported no remaining Clearside Biomedical position as of Q3 2016 after selling out during the quarter.
  • Alyeska Investment Group sold 10,000 Clearside Biomedical shares in Q3 2016, an estimated $1.05M.
  • Alyeska Investment Group first reported a position in Clearside Biomedical in Q2 2016 and held it in 1 quarter.
  • Alyeska Investment Group's Clearside Biomedical position peaked at $1.05M in Q2 2016.
  • 30 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2016.

Based on Alyeska Investment Group's 13F filing for Q3 2016, filed 14 Nov 2016.